A new study looking at nearly 877,000 people with type 2 diabetes found that patients who used GLP-1 medications had a higher risk of developing issues with their sense of smell and taste compared to those who took other diabetes medications
AimraneALaaradiaMASerenoDPerrinPDraouiABougadirBet al
Bibcode:1991AcCrB..47..918D
Nahrungsergnzungsmittel auerhalb der Reichweite von kleinen Kindern lagern
The extensive analysis and description of several adverse events that affect more than 10% of patients emphasizes the need for vigilant monitoring and effective management of these issues in a clinical setting
Bass LS, Kaufman-Janette J, Joseph JH, Kaminer MS, Clark J, Fabi SG, Gold MH, Katz BE, Peddy K, Schlessinger J, Young VL, Hurley D, McLane MP, Vijayan S, Liu G, Davis MW, Goldman MP